Congratulations to the 2019 Winners!
In the Public Therapeutic Biotech category, nominated companies are actively developing a therapeutic product intended for FDA review that addresses human health issues and must be publicly traded.The Buzz of BIO contest provides an excellent opportunity for early-stage companies looking to make the connections needed to take their product to the next phase. Ten biotechs were nominated in each of the three categories: Public Therapeutic Biotech, Private Therapeutic Biotech, and our newest category, Diagnostics and Beyond. The companies with the most number of votes in each category at the end of the voting period won a complimentary conference registration and company presentation, along with exposure to thousands of industry elites and potential investors. Please note that this contest is only open to companies headquartered in the United States.
- In the Private Therapeutic Biotech category, nominated companies are actively developing a therapeutic product intended for FDA review that addresses human health issues and must have raised at least $25MM by November 2017, but must not yet be publicly traded.
- In the Diagnostics and Beyond category, nominated companies are primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.
Read the 2019 official contest rules here.